Abstract Non-small cell lung carcinoma (NSCLC) remains a leading cause of cancer-related deaths, with KRAS mutations conferring oncogene addiction and chemoresistance to therapy. Our previous work demonstrated that Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) inversely correlates with KRAS dependency and promotes epithelial-mesenchymal transition (EMT). Given the role of TIMP-1 in tumor progression, we investigated how TIMP-1 modulation impacts the expression of angiogenic mediators in NSCLC cells.KRAS-dependent (H441) and KRAS-independent (H460) NSCLC cell lines were modulated to overexpress (OE) or knock down (KD) TIMP-1, respectively. Serum free conditioned media from these cells was analyzed using angiogenesis proteome profiler array (R Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7477.
M-Thirusenthilarasan et al. (Fri,) studied this question.